Intraoperative radiotherapy in the treatment of neuroblastoma: Report of a pilot study
- 21 Downloads
Background: External beam radiotherapy in advanced neuroblastoma is limited by the volume of normal radiosensitive tissues included in the radiation field. Limitations to external radiation are the late effects to these tissues. Intraoperative radiotherapy (IORT) delivers a single high-radiation dose to a tumor while displacing normal tissues that would have been included in an external field. Standard external radiotherapy can still be done after “boost” IORT.
Methods: Eight advanced-stage neuroblastoma patients who received IORT as part of their multimodality therapy were reviewed to identify the impact of IORT on operative time, complications, and tumor control in the treatment field. The IORT was accomplished by patient transport from the OR to the radiation therapy suite; these were separated by three floors.
Results: IORT added 30–75 min to the operative procedure. Tumors in the resection/IORT fields showed no evidence of disease (one), stable tumor size (six), and tumor recurrence (one). Two complications were identified: a urinary fistula and CO2 retention, which was detected and corrected before the IORT. Neither of these complications was related to the IORT. Two patients who had subsequent tumor resection after IORT demonstrated tumor differentiation to ganglioneuromatous tissue.
Conclusions: IORT usually can be completed in less than an hour. No IORT-associated complications were identified. IORT along with maximal tumor resection, external radiation, and chemotherapy enhances local tumor control.
Key WordsNeuroblastoma Intraoperative radiotherapy Intraoperative radiation therapy IORT
Unable to display preview. Download preview PDF.
- 1.Brodeur GM, Castleberry RP. Neuroblastoma. In: Pizzo PA, Poplack DG, eds.Principles and practice of pediatric oncology. Philadelphia: JB Lippincott, 1993:739–67.Google Scholar
- 8.Everson TC, Cole WH. Spontaneous regression of neuroblastoma. In: Everson TC, Cole WH, eds.Spontaneous regression of cancer. Philadelphia: WB Saunders, 1966:88.Google Scholar
- 9.Cushing H, Wolbach SB. The transformation of a malignant paravertebral sympathicoblastoma into a benign ganglioneuroma.Am J Pathol 1927;3:203–16.Google Scholar
- 10.Pizzo PA, Poplack DG, Horowitz ME, Hayes DM, Kun LE. Solid tumors of childhood. In: Devita VT Jr, Hellman S, Rosenberg SA, eds.Cancer principles and practice of oncology. 4th ed. Philadelphia: JB Lippincott, 1993:1738–91.Google Scholar
- 12.Wheldon TE, Berry I, O'Donoghue JA, Gretor A, Hann IM, Livingston A, Russell J, et al. The effect on human neuroblastoma spheroids of fractionated radiation regimens calculated to be equivalent for damage to late responding normal tissues.Eur J Cancer Clin Oncol 1987;23:855–66.CrossRefPubMedGoogle Scholar
- 13.Kinsella TJ, Sindelar WF. Intraoperative radiotherapy. In: Devita VT, Hellman S, Rosenberg SA, eds.Cancer principles and practice of oncology. Philadelphia: JB Lippincott, 1985:2293–304.Google Scholar
- 14.Merrick HW III. General surgical aspects of intraoperative radiation therapy. In: Dobelbower RR Jr, Abe M, eds.Intraoperative radiation therapy. Boca Raton: CRC Press, 1989:113–21.Google Scholar
- 15.Archambeau JO, Aitken D, Potts TM, Slater JM. Cost-effective, available-on-demand intraoperative radiation therapy.Int J Radiation Oncol Biol Phys 1988;15:775–8.Google Scholar
- 16.Wolkov HB. The economics of intraoperative radiation therapy. In: Dobelbower RR Jr, Abe M, eds.Intraoperative radiation therapy. Boca Raton: CRC Press, 1989:393–400.Google Scholar
- 18.Hodel PE, Martin JT. Anesthesiologic considerations for intraoperative radiation therapy. In: Dobelbower RR Jr, Abe M, eds.Intraoperative radiation therapy. Boca Raton: CRC Press, 1989:75–81.Google Scholar
- 20.Evans AE. Natural history of neuroblastoma. In: Evans AE, ed.Advances in neuroblastoma research. New York: Raven Press, 1980:3.Google Scholar